Fatal ergotism induced by an HIV protease inhibitor [2]

Headache

Volumn 42, Issue 7, 2002, Pages 694-695

  Tribble, Marc A ^a,b   Gregg, Clark R ^a,b   Margolis, David M ^a,b   Amirkhan, Robin ^a,b   Smith, James W ^a,b  

^a Southwestern Medical Center ^*  (United Kingdom)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYTOCHROME P450; ERGOT ALKALOID; ERGOTAMINE; INDINAVIR; LAMIVUDINE; PROTEINASE INHIBITOR; STAVUDINE; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIMICROBIAL THERAPY; AUTOPSY; BRAIN DEATH; BRAIN DISEASE; BRAIN ISCHEMIA; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME METABOLISM; ERGOTISM; HERNIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; HYPOTENSION; LETTER; LIVEDO RETICULARIS; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; RNA ANALYSIS; TIME; VASOCONSTRICTION;

EID: 0036657012     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02163.x     Document Type: Letter

References (5)

1. Drug interactions of HIV protease inhibitors
2. Ergotism related to interaction between nelfinavir and ergotamine
3. Ergotism related to concurrent administration of ergotamine tartrate and indinavir
4. Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient
5. Cerebral ergotism under treatment with ertotamine and ritonavir